US 9107883
Compounds and methods for treating aberrant adrenocartical cell disorders
granted A61KA61K31/03A61K31/155
Quick answer
US patent 9107883 (Compounds and methods for treating aberrant adrenocartical cell disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/03, A61K31/155, A61K31/17, A61K31/436